Zu "935283-04-8" wurden 2 Artikel gefunden!

Für die Filterung wurden keine Ergebnisse gefunden!
Linzagolix
Linzagolix

Artikelnummer: TGM-T27837-10mg

Description: Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis. As of December 2020, it is under review for...
Anwendung: Targets gonadotropin-releasing hormone receptor (GNRHR)
CAS 935283-04-8
MW: 508.42 D
ab 48,00 €
Bewerten
Linzagolix
Linzagolix

Artikelnummer: Cay39654-1

Linzagolix is a nonpeptide gonadotropin-releasing hormone (GnRH) receptor antagonist (IC50 = 36.7 nM for the human receptor). Unlike the peptide GnRH receptor antagonist cetrorelix (Cay-23910), linzagolix (10 µM) does not induce histamine release in isolated rat peritoneal mast cells. Linzagolix (25 and 50 mg/kg)...
Schlagworte: KLH-2109, OBE-2109,...
Anwendung: GnRH receptor antagonist
CAS 935283-04-8
MW: 508.4 D
ab 47,00 €
Bewerten